203 related articles for article (PubMed ID: 24489016)
1. Association of rheumatoid arthritis susceptibility gene with lipid profiles in patients with rheumatoid arthritis.
Davis LA; Whitfield E; Cannon GW; Wolff RK; Johnson DS; Reimold AM; Kerr GS; Richards JS; Mikuls TR; Caplan L
Rheumatology (Oxford); 2014 Jun; 53(6):1014-21. PubMed ID: 24489016
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis.
Toms TE; Panoulas VF; Smith JP; Douglas KM; Metsios GS; Stavropoulos-Kalinoglou A; Kitas GD
Ann Rheum Dis; 2011 Jun; 70(6):1025-32. PubMed ID: 21398331
[TBL] [Abstract][Full Text] [Related]
3. Association of STAT4 rs7574865 and PTPN22 rs2476601 polymorphisms with rheumatoid arthritis and non-systemically reacting antibodies in Egyptian patients.
El-Lebedy D; Raslan H; Ibrahim A; Ashmawy I; El-Aziz SA; Mohammed AM
Clin Rheumatol; 2017 Sep; 36(9):1981-1987. PubMed ID: 28424905
[TBL] [Abstract][Full Text] [Related]
4. Association between low density lipoprotein and rheumatoid arthritis genetic factors with low density lipoprotein levels in rheumatoid arthritis and non-rheumatoid arthritis controls.
Liao KP; Diogo D; Cui J; Cai T; Okada Y; Gainer VS; Murphy SN; Gupta N; Mirel D; Ananthakrishnan AN; Szolovits P; Shaw SY; Raychaudhuri S; Churchill S; Kohane I; Karlson EW; Plenge RM
Ann Rheum Dis; 2014 Jun; 73(6):1170-5. PubMed ID: 23716066
[TBL] [Abstract][Full Text] [Related]
5. High density lipoprotein in rheumatoid arthritis: emerging role in predicting inflammation level and osteoporosis occurrence.
Zeng T; Tan L; Yu J; Wu Y
Scand J Clin Lab Invest; 2020 Sep; 80(5):375-380. PubMed ID: 32279574
[TBL] [Abstract][Full Text] [Related]
6. Association of PTPN22 rs2476601 and STAT4 rs7574865 polymorphisms with rheumatoid arthritis: A meta-analysis update.
Elshazli R; Settin A
Immunobiology; 2015 Aug; 220(8):1012-24. PubMed ID: 25963842
[TBL] [Abstract][Full Text] [Related]
7. Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.
Karlson EW; Chibnik LB; Cui J; Plenge RM; Glass RJ; Maher NE; Parker A; Roubenoff R; Izmailova E; Coblyn JS; Weinblatt ME; Shadick NA
Ann Rheum Dis; 2008 Mar; 67(3):358-63. PubMed ID: 17666451
[TBL] [Abstract][Full Text] [Related]
8. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.
Potter C; Hyrich KL; Tracey A; Lunt M; Plant D; Symmons DP; Thomson W; Worthington J; Emery P; Morgan AW; Wilson AG; Isaacs J; Barton A;
Ann Rheum Dis; 2009 Jan; 68(1):69-74. PubMed ID: 18375541
[TBL] [Abstract][Full Text] [Related]
9. HLA-DRB1 shared epitope alleles in patients with rheumatoid arthritis: relation to autoantibodies and disease severity in a south Indian population.
Konda Mohan V; Ganesan N; Gopalakrishnan R; Venkatesan V
Int J Rheum Dis; 2017 Oct; 20(10):1492-1498. PubMed ID: 27943654
[TBL] [Abstract][Full Text] [Related]
10. PTPN22 1858 C/T polymorphism is associated with alteration of cytokine profiles as a potential pathogenic mechanism in rheumatoid arthritis.
Ghorban K; Ezzeddini R; Eslami M; Yousefi B; Sadighi Moghaddam B; Tahoori MT; Dadmanesh M; Salek Farrokhi A
Immunol Lett; 2019 Dec; 216():106-113. PubMed ID: 31669381
[TBL] [Abstract][Full Text] [Related]
11. Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis.
Rizzo M; Spinas GA; Cesur M; Ozbalkan Z; Rini GB; Berneis K
Atherosclerosis; 2009 Dec; 207(2):502-6. PubMed ID: 19643412
[TBL] [Abstract][Full Text] [Related]
12. Association of polymorphisms modulating low-density lipoprotein cholesterol with susceptibility, severity, and progression of rheumatoid arthritis.
Park YJ; Yoo SA; Choi S; Yoo HS; Yoon HS; Cho CS; Yoo KD; Kim WU
J Rheumatol; 2013 Jun; 40(6):798-808. PubMed ID: 23588940
[TBL] [Abstract][Full Text] [Related]
13. Association of anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes with HLA-DRB1 shared epitope alleles in Egyptian rheumatoid arthritis patients.
Raslan HM; Attia HR; Hamed Ibrahim M; Mahmoud Hassan E; Salama II; Ismail S; Abdelmotaleb E; El Menyawi MM; Amr KS
Int J Rheum Dis; 2020 May; 23(5):647-653. PubMed ID: 32167241
[TBL] [Abstract][Full Text] [Related]
14. The APOM polymorphism as a novel risk factor for dyslipidaemia in rheumatoid arthritis: a possible shared link between disease susceptibility and dyslipidaemia.
Park YJ; Yoo SA; Lee JH; Chung YJ; Cho CS; Kim W-
Clin Exp Rheumatol; 2013; 31(2):180-8. PubMed ID: 23190940
[TBL] [Abstract][Full Text] [Related]
15. Association of PTPN22 1858C→T polymorphism, HLA-DRB1 shared epitope and autoantibodies with rheumatoid arthritis.
Raslan HM; Attia HR; Salama I; Ibrahim MH; Hassan EM; El Hussieny MS; El Menyawi MM; Amr KS
Rheumatol Int; 2016 Aug; 36(8):1167-75. PubMed ID: 27324632
[TBL] [Abstract][Full Text] [Related]
16. [Atherosclerosis in rheumatoid arthritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness].
Carotti M; Salaffi F; Mangiacotti M; Cerioni A; Giuseppetti GM; Grassi W
Reumatismo; 2007; 59(1):38-49. PubMed ID: 17435841
[TBL] [Abstract][Full Text] [Related]
17. Plasma kinetics of an LDL-like non-protein nanoemulsion and transfer of lipids to high-density lipoprotein (HDL) in patients with rheumatoid arthritis.
Pozzi FS; Maranhão RC; Guedes LK; Borba EF; Laurindo IM; Bonfa E; Vinagre CG
J Clin Lipidol; 2015; 9(1):72-80. PubMed ID: 25670363
[TBL] [Abstract][Full Text] [Related]
18. [Association between systemic inflammation and autoimmunity parameters and plasma lipid in patients with rheumatoid arthritis].
Xue C; Liu WL; Sun YH; Ding RJ; Hu DY
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):941-5. PubMed ID: 22321280
[TBL] [Abstract][Full Text] [Related]
19. High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein.
Rodríguez-Carrio J; Alperi-López M; López P; López-Mejías R; Alonso-Castro S; Abal F; Ballina-García FJ; González-Gay MÁ; Suárez A
J Clin Lipidol; 2017; 11(4):1043-1054.e2. PubMed ID: 28662934
[TBL] [Abstract][Full Text] [Related]
20. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.
Gabay C; McInnes IB; Kavanaugh A; Tuckwell K; Klearman M; Pulley J; Sattar N
Ann Rheum Dis; 2016 Oct; 75(10):1806-12. PubMed ID: 26613768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
